DARYL KROUSE: Open Payments
NPI 1245462696 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 104 payments from 14 companies in 2025. Trend: 2023 $1,415 · 2024 $1,809 · 2025 $1,463
Food & beverage: $1,463
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $234 |
| Otsuka America Pharmaceutical, Inc. | 13 | $207 |
| ABBVIE INC. | 17 | $182 |
| Teva Pharmaceuticals USA, Inc. | 18 | $180 |
| E.R. Squibb & Sons, L.L.C. | 11 | $146 |
| Alkermes, Inc. | 7 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $50 |
Products named: INGREZZA, REXULTI, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, TRINTELLIX, FANAPT.
Industry payments across PA — which companies pay providers there.
